2026 Summer Intern – Uro-Oncology Market Access Marketing & Strategy (Graduate-level) at Acadia Pharmaceuticals

Parsippany, New Jersey, United States

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Biopharmaceutical, Healthcare, OncologyIndustries

Requirements

  • Currently enrolled in a graduate program in computer science, health care administration, or public health
  • Demonstrated proficiency in database management, Excel, SQL, SAS
  • Strong analytical and problem-solving skills
  • Excellent communication and teamwork abilities
  • Eagerness to learn and adapt in a fast-paced environment
  • For Parsippany-based roles: Expected to work no less than 4 days at the site in Parsippany, New Jersey, with potential for 1 day remote per week
  • Ability to complete the entire 10-week program (May 26, 2026 to July 31, 2026) and commit to 37.5 hours per week
  • Cumulative 3.0 GPA or above; college transcript required (must mail official transcript by application deadline)
  • Currently enrolled in an accredited U.S.-based college or university (undergraduate, graduate, MBA, JD, PharmD, or PhD program)
  • Legally authorized to work in the U.S. without need for sponsorship/CPT/OPT now or in the future
  • At least 18 years of age prior to the scheduled start date
  • Must be available to complete virtual interviews with HR and hiring manager
  • Must successfully pass a drug screen and background check prior to start date
  • Must complete a final presentation at the end of the program

Responsibilities

  • Create and manage Uro-Oncology Market Access data warehouse
  • Identify key public and private databases that may be used to support Uro-Oncology Market Access decision making
  • Work with key internal data stakeholders to determine opportunities for data collection collaboration
  • Analyze databases to identify relevant data elements and data gaps
  • Collaborate with Uro-Oncology team to create standardized reports to guide development of Uro-Oncology Market Access strategies
  • Develop Uro-Oncology Market Access dashboard to communicate updates on KPIs and other key deliverables

Skills

Key technologies and capabilities for this role

Market AccessData AnalysisDashboard DevelopmentStakeholder CollaborationStrategic Decision-MakingOncology MarketingUro-Oncology

Questions & Answers

Common questions about this position

What are the required qualifications for this internship?

Candidates must be currently enrolled in a graduate program in computer science, health care administration, or public health, with demonstrated proficiency in database management, Excel, SQL, and SAS, plus strong analytical, problem-solving, communication, and teamwork skills.

Is this internship remote or office-based?

This role is expected to work no less than 4 days at the site in Parsippany, New Jersey.

What is the compensation for this summer internship?

This information is not specified in the job description.

What is the company culture like at Ferring?

Ferring emphasizes a 'people first' philosophy, entrepreneurial spirit, long-term perspective, and a commitment to science and research, and is Great Places to Work® Certified.

What makes a strong candidate for this Uro-Oncology internship?

A strong candidate will be enrolled in a relevant graduate program and show eagerness to learn and adapt in a fast-paced environment, along with proficiency in key technical skills like SQL and database management.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI